Printer icon Print Page

Research and Reports

HTA and Drug Pricing

The National Pharmacare Initiative (NPI)

Ensuring affordable access to pharmaceuticals is not a new challenge in Canadian health care. The rapid emergence of new innovative medicines offers unprecedented opportunities for patients. At the same time, concern regarding the cost of pharmaceuticals has reached historic levels.

Op-Ed: Through the lens of value-based health care: oncology care

Concerns are growing over Canada’s health-care system not delivering value for the money spent. Despite being considered one of the highest spenders on health care....Click here to read more.

Views From the Front Line: Taking the Pulse of Canada’s Healthcare Professionals

Click here to read the report.
Chad Leaver
Director, Health

Isabella Moroz
Senior Research Associate II